This antibody is a mouse monoclonal antibody binding with interleukin 23 subunit alpha (IL23A). It specifically binds to human IL-23A. It can also be potentially used in the research of rheumatoid arthritis. This product has been tested using Enzyme-linked immunosorbent assay and Inhibition assay.
Figure 1 Binding of anti-IL-23 mAbs to human IL-23.
Figure 2 shows the ability of tissue culture supernatant chimeric 8C92H6 HC1 LC1 to bind to human IL-23.
Figure 3 show the ability of purified chimeric 8C92H6 HC1 LC1 to inhibit human IL-23 binding to human IL-23R.
Figure 4 shows the ability of tissue culture supernatant containing chimeric 8C92H6 HC1 LC1 to inhibit human IL-23 binding to human IL-23R.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-1953-VHH | Recombinant Anti-human IL23A VHH Single Domain Antibody | WB, IP, ICC, FC, FA | Llama VHH |
TAB-005LC-VHH | Anti-human IL23A Recombinant Antibody (TAB-005LC-VHH) | ELISA | Single domain antibody |
There are currently no Customer reviews or questions for TAB-614LC. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.